Logo image of OBE

OBSIDIAN ENERGY LTD (OBE) Stock Fundamental Analysis

NYSEARCA:OBE - NYSE Arca - CA6744822033 - Common Stock - Currency: USD

5.36  -0.11 (-2.01%)

After market: 5.36 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OBE. OBE was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. OBE has a bad profitability rating. Also its financial health evaluation is rather negative. OBE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OBE has reported negative net income.
OBE had a positive operating cash flow in the past year.
In multiple years OBE reported negative net income over the last 5 years.
Each year in the past 5 years OBE had a positive operating cash flow.
OBE Yearly Net Income VS EBIT VS OCF VS FCFOBE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

OBE has a Return On Assets of -9.16%. This is amonst the worse of the industry: OBE underperforms 82.86% of its industry peers.
Looking at the Return On Equity, with a value of -14.10%, OBE is doing worse than 77.14% of the companies in the same industry.
OBE's Return On Invested Capital of 8.14% is fine compared to the rest of the industry. OBE outperforms 67.14% of its industry peers.
OBE had an Average Return On Invested Capital over the past 3 years of 8.82%. This is significantly below the industry average of 23.80%.
Industry RankSector Rank
ROA -9.16%
ROE -14.1%
ROIC 8.14%
ROA(3y)10.66%
ROA(5y)-3.82%
ROE(3y)14.48%
ROE(5y)-28.26%
ROIC(3y)8.82%
ROIC(5y)8.37%
OBE Yearly ROA, ROE, ROICOBE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

OBE has a better Operating Margin (26.36%) than 60.95% of its industry peers.
In the last couple of years the Operating Margin of OBE has declined.
OBE has a Gross Margin of 70.77%. This is in the better half of the industry: OBE outperforms 80.00% of its industry peers.
In the last couple of years the Gross Margin of OBE has grown nicely.
Industry RankSector Rank
OM 26.36%
PM (TTM) N/A
GM 70.77%
OM growth 3Y-12.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y2.34%
OBE Yearly Profit, Operating, Gross MarginsOBE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OBE is destroying value.
OBE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, OBE has more shares outstanding
Compared to 1 year ago, OBE has a worse debt to assets ratio.
OBE Yearly Shares OutstandingOBE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
OBE Yearly Total Debt VS Total AssetsOBE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 0.70, we must say that OBE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.70, OBE is doing worse than 60.95% of the companies in the same industry.
A Debt/Equity ratio of 0.25 indicates that OBE is not too dependend on debt financing.
The Debt to Equity ratio of OBE (0.25) is better than 68.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACC0.83
WACC9.82%
OBE Yearly LT Debt VS Equity VS FCFOBE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 1.56 indicates that OBE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.56, OBE is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
OBE has a Quick Ratio of 1.56. This is a normal value and indicates that OBE is financially healthy and should not expect problems in meeting its short term obligations.
OBE has a Quick ratio of 1.56. This is in the better half of the industry: OBE outperforms 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
OBE Yearly Current Assets VS Current LiabilitesOBE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for OBE have decreased strongly by -347.08% in the last year.
OBE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.94%.
OBE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.38% yearly.
EPS 1Y (TTM)-347.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)15.94%
Revenue growth 3Y17.6%
Revenue growth 5Y13.38%
Sales Q2Q%12.33%

3.2 Future

Based on estimates for the next years, OBE will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
OBE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.29% yearly.
EPS Next Y120.67%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.95%
Revenue Next 2Y-3.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OBE Yearly Revenue VS EstimatesOBE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
OBE Yearly EPS VS EstimatesOBE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OBE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OBE Price Earnings VS Forward Price EarningsOBE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

95.24% of the companies in the same industry are more expensive than OBE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2
OBE Per share dataOBE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as OBE's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OBSIDIAN ENERGY LTD

NYSEARCA:OBE (7/15/2025, 8:04:02 PM)

After market: 5.36 0 (0%)

5.36

-0.11 (-2.01%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners27.43%
Inst Owner Change0%
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap370.97M
Analysts72.5
Price Target7.09 (32.28%)
Short Float %5.9%
Short Ratio8.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.4%
PT rev (3m)-21.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-84.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF 1.27
P/B 0.36
P/tB 0.36
EV/EBITDA 2
EPS(TTM)-1.96
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)4.23
OCFY78.84%
SpS8.07
BVpS14.92
TBVpS14.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.16%
ROE -14.1%
ROCE 10.83%
ROIC 8.14%
ROICexc 8.15%
ROICexgc 8.15%
OM 26.36%
PM (TTM) N/A
GM 70.77%
FCFM N/A
ROA(3y)10.66%
ROA(5y)-3.82%
ROE(3y)14.48%
ROE(5y)-28.26%
ROIC(3y)8.82%
ROIC(5y)8.37%
ROICexc(3y)8.83%
ROICexc(5y)8.4%
ROICexgc(3y)8.83%
ROICexgc(5y)8.4%
ROCE(3y)11.73%
ROCE(5y)11.13%
ROICexcg growth 3Y-18.98%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.98%
ROICexc growth 5YN/A
OM growth 3Y-12.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y2.34%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA 0.81
Cap/Depr 187.25%
Cap/Sales 57.68%
Interest Coverage 6.12
Cash Conversion 91.57%
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.7
F-Score5
WACC9.82%
ROIC/WACC0.83
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)47.68%
Cap/Sales(5y)38.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-347.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y120.67%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.94%
Revenue growth 3Y17.6%
Revenue growth 5Y13.38%
Sales Q2Q%12.33%
Revenue Next Year-13.95%
Revenue Next 2Y-3.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.09%
EBIT growth 3Y3.18%
EBIT growth 5YN/A
EBIT Next Year67.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-133.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.24%
OCF growth 3Y22.12%
OCF growth 5Y36.28%